BioSpace News Archive

Drug Development

Eurocine Vaccines has Completed Dosing of its Quadrivalent Influenza Vaccine Candidate, Immunose™ FLU, in the Second Clinical Study

Immunose™ FLU was developed with the aim to become a modern and effective nasal influenza vaccine.

May 18, 2018

·

1 min read

Biotech Beach

KARL STORZ Announces New Non-Muscle Invasive Bladder Cancer Detection System: Photodynamic Diagnosis (PDD) Blue Light Flexible Video Cystoscopy

New indications greatly increase the treatment possibilities of this innovative therapy, which has rapidly become the standard of care for bladder cancer treatment at major medical institutions across the United States.

May 18, 2018

·

6 min read

Pharm Country

Amneal Pharmaceuticals Celebrates Combination by Ringing Opening Bell at New York Stock Exchange

Founders along with members of management will ring the opening bell at the New York Stock Exchange this morning at 9:30 a.m. ET.

May 18, 2018

·

7 min read

Business

Apexigen Expands Leadership Team With Appointment Of Frances Rena Bahjat, Ph.D. Vice President, Discovery Research

Apexigen, is a clinical-stage biopharmaceutical company

May 18, 2018

·

3 min read

Business

Centene Subsidiary Awarded Correctional Healthcare Contract In Tucson, Arizona

The contract will be administered by the County’s Department of Behavioral Health and is expected to commence July 1, 2018, with a base term of three years, plus two optional years to renew.

May 18, 2018

·

10 min read

Policy

DaVita Celebrates Signing of the Colorado Living Donor Support Act

Thousands of Colorado patients awaiting life-sustaining transplants will also benefit from this legislation once the bill goes into effect in 2020.

May 18, 2018

·

3 min read

Business

Cronos Group Inc. Appoints Lead Director, Engages Investor Relations Agency and Grants Options

Jim Rudyk appointed as lead director and has entered into an engagement agreement to retain Athena Advisors LLC as its agency of record for investor relations and corporate communications.

May 18, 2018

·

5 min read

Biotech Bay

Kaiser Permanente Announces $200 Million Impact Investment, Partners with U.S. Mayors and CEOs to Address Housing Stability

Investment marks a significant funding commitment to homelessness prevention

May 18, 2018

·

3 min read

Pharm Country

Regeneron Announces Upcoming Investor Conference Presentation

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its management presentation at the Goldman Sachs 39th Annual Global Healthcare Conference at 8:40 a.m. Pacific Time (11:40 a.m. Eastern Time) on Tuesday, June 12, 2018.

May 18, 2018

·

1 min read

Pharm Country

$325K NIH Grant to EpiVax to Enable Development of Personalized Immunogenicity Assessment Tool for Enzyme Replacement Therapy in Pompe Disease

The National Institutes of Health (NIH) has awarded EpiVax, Inc. (“EpiVax”), experts in the field of immunogenicity risk assessment, a $324,980 Small Business Innovation Research (SBIR) grant.

May 18, 2018

·

2 min read